Some Additional Considerations Regarding the American Society of Addiction Medicine National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use
2016; Lippincott Williams & Wilkins; Volume: 10; Issue: 3 Linguagem: Inglês
10.1097/adm.0000000000000219
ISSN1935-3227
AutoresAndrew J. Saxon, Elinore F. McCance‐Katz,
Tópico(s)Pharmacology and Obesity Treatment
ResumoCenter of Excellence in Substance Abuse Treatment and Education (AJS), VA Puget Sound Health Care System, Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA; and Rhode Island Department of Behavioral Health (EFM-K), Developmental Disabilities and Hospitals, Cranston, RI. Send correspondence and reprint requests to Andrew J. Saxon, MD, VA Puget Sound Health Care System, 1660 S. Columbian Wy., Seattle, WA 98108. E-mail: [email protected]. Received 28 September, 2015 Accepted 27 March, 2016 Funding: Dr Saxon's work on this commentary was supported by the Center of Excellence in Substance Abuse Treatment and Education, VA Puget Sound Health Care System. The authors report no conflicts of interest.
Referência(s)